Other

Estimated reimbursements to wholesalers and distributors

Moderna Estimated reimbursements to wholesalers and distributors increased by 32.1% to $111.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 38.0%, from $179.00M to $111.00M.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2023
Last reportedQ1 2026May 1, 2026
Metric ID: other_reimbursement_liability_current

Historical Data

8 periods
 Q4 '23Q1 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$0.00$119.00M$103.00M$179.00M$118.00M$0.00$84.00M$111.00M
QoQ Change-13.4%+73.8%-34.1%-100.0%+32.1%
YoY Change+50.4%-18.4%-38.0%
Range$0.00$179.00M
Avg YoY Growth-2.0%
Median YoY Growth-18.4%

Frequently Asked Questions

What is Moderna's estimated reimbursements to wholesalers and distributors?
Moderna (MRNA) reported estimated reimbursements to wholesalers and distributors of $111.00M in Q1 2026.
How has Moderna's estimated reimbursements to wholesalers and distributors changed year-over-year?
Moderna's estimated reimbursements to wholesalers and distributors decreased by 38.0% year-over-year, from $179.00M to $111.00M.